147 related articles for article (PubMed ID: 35416117)
1. Discoidin domain receptor 1a (DDR1a) confers 5-fluorouracil cytotoxicity in LoVo cell via PI3K/AKT/Bcl-2 pathway.
Xiong B; Song FX; Chen HL; Wang XJ; Jin ZX; Han TY; Li Y; Zhang DK
Bioengineered; 2022 Apr; 13(4):9805-9814. PubMed ID: 35416117
[TBL] [Abstract][Full Text] [Related]
2. DDR1 promotes LoVo cell proliferation by regulating energy metabolism.
Xiong B; Xie Z; Song F; Chen H; Wang X; Jin Z; Han T; Li Y; Zhang D
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):615-624. PubMed ID: 35593476
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
4. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
[TBL] [Abstract][Full Text] [Related]
5. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway.
Liu G; Zhou J; Dong M
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842340
[TBL] [Abstract][Full Text] [Related]
7. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
[TBL] [Abstract][Full Text] [Related]
8. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
9. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells.
Zhu Y; Yu J; Wang S; Lu R; Wu J; Jiang B
Oncol Rep; 2014 Dec; 32(6):2437-44. PubMed ID: 25230779
[TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.
Ram R; Lorente G; Nikolich K; Urfer R; Foehr E; Nagavarapu U
J Neurooncol; 2006 Feb; 76(3):239-48. PubMed ID: 16234985
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
Wang Y; Liu X; Liu J; Zhang T
Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
[No Abstract] [Full Text] [Related]
13. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
15. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
17. Curcumae longae Rhizoma (Jianghuang) extract reverses the 5-Fluoruracil resistance in colorectal cancer cells via TLR4/PI3K/Akt/mTOR pathway.
Teng Z; Sun X; Guo Y; Zhang M; Liu Y; Xu M
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101976. PubMed ID: 35710041
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase.
Park HS; Kim KR; Lee HJ; Choi HN; Kim DK; Kim BT; Moon WS
Oncol Rep; 2007 Dec; 18(6):1435-41. PubMed ID: 17982627
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]